Five things to know:
1. The percentage of outpatient visits for influenzalike illness remained at 2.2 percent, the national baseline.
2. The percentage of respiratory specimens testing positive for flu remains low. The CDC confirmed 613 positive specimens for influenza A and 52 positive specimens for influenza B in the week ending Dec. 8.
3. The CDC reported 544 laboratory-confirmed flu-associated hospitalizations from Oct. 1 through Dec. 8. The overall flu-associated hospitalization rate was 1.9 per 100,000 population.
4. One pediatric flu death was reported to CDC for the week ending Dec. 8. A total of six pediatric flu deaths have been reported for the 2018-19 season.
5. California, Georgia and Massachusetts reported widespread flu activity for the week ending Dec. 8. Ten states reported regional flu activity; 21 states reported local flu activity; and 16 states reported sporadic activity.
More articles on clinical leadership and infection control:
Stamford Hospital fined for running blood center without certification
Congo pediatric patient born with Ebola in recovery; death toll at 303
Kentucky hospital sees increase in pediatric RSV cases
The percentage of outpatient visits for influenzalike illness remained at 2.2 percent, the national baseline.
The percentage of respiratory specimens testing positive for flu remains low. The CDC confirmed 613 positive specimens for influenza A and 52 positive specimens for influenza B in the week ending Dec. 8.
The CDC reported 544 laboratory-confirmed flu-associated hospitalizations from Oct. 1 through Dec. 8. The overall flu-associated hospitalization rate was 1.9 per 100,000 population.
One pediatric flu death was reported to CDC for the week ending Dec. 8. A total of six pediatric flu deaths have been reported for the 2018-19 season.
California, Georgia and Massachusetts reported widespread flu activity for the week ending Dec. 8. Ten states reported regional flu activity; 21 states reported local flu activity; and 16 states reported sporadic activity.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
